161 related articles for article (PubMed ID: 26112867)
1. Cumulative Effects of Several Target Organ Damages in Risk Assessment in Hypertension.
Harbaoui B; Courand PY; Defforges A; Khettab F; Milon H; Girerd N; Lantelme P
Am J Hypertens; 2016 Feb; 29(2):234-44. PubMed ID: 26112867
[TBL] [Abstract][Full Text] [Related]
2. Association between left ventricular hypertrophy with retinopathy and renal dysfunction in patients with essential hypertension.
Shirafkan A; Motahari M; Mojerlou M; Rezghi Z; Behnampour N; Gholamrezanezhad A
Singapore Med J; 2009 Dec; 50(12):1177-83. PubMed ID: 20087555
[TBL] [Abstract][Full Text] [Related]
3. Clustering of target organ damage increases mortality after acute coronary syndromes in patients with arterial hypertension.
Cordero A; Morillas P; Bertomeu-Gonzalez V; Quiles J; Mazón P; Guindo J; Soria F; Llácer A; Lekuona I; Gonzalez-Juanatey JR; Bertomeu V;
J Hum Hypertens; 2011 Oct; 25(10):600-7. PubMed ID: 21160527
[TBL] [Abstract][Full Text] [Related]
4. Target organ damage assessment in French hypertensive patients without established cardiovascular or renal disease: results of the PREVENT-A study.
Rossignol P; Hosseini K; Tropeano AI; Fay R; Tsatsaris A; Guillemin F; Mounier-Vehier C
J Hypertens; 2013 Jan; 31(1):177-85. PubMed ID: 23111625
[TBL] [Abstract][Full Text] [Related]
5. Relation between grade II hypertensive retinopathy and coronary artery disease in treated essential hypertensives.
Kim GH; Youn HJ; Kang S; Choi YS; Moon JI
Clin Exp Hypertens; 2010; 32(7):469-73. PubMed ID: 21029012
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of combined target-organ damage in patients with essential hypertension.
Carpinella G; Pagano G; Buono F; Petitto M; Guarino G; Orefice G; Rengo G; Trimarco B; Morisco C
Am J Hypertens; 2015 Jan; 28(1):127-34. PubMed ID: 24936579
[TBL] [Abstract][Full Text] [Related]
7. [Association between hypertensive left ventricular hypertrophy and cardiovascular events in adult Beijing residents: a cohort study].
Li Y; Zhao D; Liu J; Li CF; Guo W; Chen CH; Hao P; Sun JY; Qin LP; Wang W
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1037-42. PubMed ID: 19102921
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of left ventricular hypertrophy and changes in left ventricular mass in high-risk hypertensive patients: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan trial.
Yasuno S; Ueshima K; Oba K; Fujimoto A; Ogihara T; Saruta T; Nakao K
J Hypertens; 2009 Aug; 27(8):1705-12. PubMed ID: 19412127
[TBL] [Abstract][Full Text] [Related]
9. Target-organ damage and cardiovascular complications in hypertensive Nigerian Yoruba adults: a cross-sectional study.
Oladapo OO; Salako L; Sadiq L; Shoyinka K; Adedapo K; Falase AO
Cardiovasc J Afr; 2012 Aug; 23(7):379-84. PubMed ID: 22914995
[TBL] [Abstract][Full Text] [Related]
10. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
11. Why is cardiovascular risk stratification important in hypertensive patients?
Coll-De-Tuero G; Saez M; Rodriguez-Poncelas A; Barceló-Rado A; Vargas-Vila S; Garre-Olmo J; Sala V; Sieira A; Gelada E; Gelado-Ferrero J
Blood Press; 2012 Jun; 21(3):182-90. PubMed ID: 22486493
[TBL] [Abstract][Full Text] [Related]
12. Association of renal resistive index with target organ damage in essential hypertension.
Doi Y; Iwashima Y; Yoshihara F; Kamide K; Takata H; Fujii T; Kubota Y; Nakamura S; Horio T; Kawano Y
Am J Hypertens; 2012 Dec; 25(12):1292-8. PubMed ID: 22874890
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination?
Cuspidi C; Macca G; Salerno M; Michev L; Fusi V; Severgnini B; Corti C; Meani S; Magrini F; Zanchetti A
Ital Heart J; 2001 Sep; 2(9):702-6. PubMed ID: 11666100
[TBL] [Abstract][Full Text] [Related]
14. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
[TBL] [Abstract][Full Text] [Related]
15. Target organ damage among hypertensive adults in rural Nigeria: a cross-sectional study.
Nelissen HE; Hendriks ME; Wit FW; Bolarinwa OA; Osagbemi GK; Bindraban NR; Lange JM; Akande TM; Schultsz C; Brewster LM
J Hypertens; 2014 Mar; 32(3):487-94. PubMed ID: 24299916
[TBL] [Abstract][Full Text] [Related]
16. Influence of metabolic syndrome on hypertension-related target organ damage.
Mulè G; Nardi E; Cottone S; Cusimano P; Volpe V; Piazza G; Mongiovì R; Mezzatesta G; Andronico G; Cerasola G
J Intern Med; 2005 Jun; 257(6):503-13. PubMed ID: 15910554
[TBL] [Abstract][Full Text] [Related]
17. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension.
Shigematsu Y; Hamada M; Mukai M; Matsuoka H; Sumimoto T; Hiwada K
J Hypertens; 1995 Jan; 13(1):155-60. PubMed ID: 7759846
[TBL] [Abstract][Full Text] [Related]
18. Target organ damage and control of cardiovascular risk factors in hypertensive patients. Evidence from the multicenter ESTher registry.
Reibis RK; Huber M; Karoff M; Kamke W; Kreutz R; Wegscheider K; Völler H
Herz; 2015 Apr; 40 Suppl 2():209-16. PubMed ID: 25630386
[TBL] [Abstract][Full Text] [Related]
19. Hypertensive target organ damage and the risk for vascular events and all-cause mortality in patients with vascular disease.
Vernooij JW; van der Graaf Y; Nathoe HM; Bemelmans RH; Visseren FL; Spiering W
J Hypertens; 2013 Mar; 31(3):492-99; discussion 499-500. PubMed ID: 23303394
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular hypertrophy and renal dysfunction during antihypertensive treatment adversely affect cardiovascular prognosis in hypertensive patients.
Salvetti M; Muiesan ML; Paini A; Monteduro C; Agabiti-Rosei C; Aggiusti C; Bertacchini F; Stassaldi D; Castellano M; Agabiti-Rosei E
J Hypertens; 2012 Feb; 30(2):411-20. PubMed ID: 22179082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
